STING1 and neoplasm: The released activated STING may subject the surrounding tumor cells to unwarranted damage and promote antitumor immunity or may be involved in the shaping of immunosuppressive TME, as previously described, with the ultimate outcome depending on which of these STING actions are operative in the tumor cells.